US Stock Market Move | Conexeu Sciences (CNXU.US) debuts on the US stock market with a drop of over 3.6% at the opening.

date
23:57 21/05/2026
avatar
GMT Eight
Conexeu Sciences is an early-stage medical technology company based in the United States, specializing in the development of regenerative medical materials based on collagen.
On Thursday, Conexeu Sciences (CNXU.US) made its debut on the US stock market, with the opening stock price dropping over 3.6% to $13.01. The IPO price was $13.5. Conexeu Sciences is an early-stage medical technology company based in the US, focusing on the development of regenerative medical materials based on collagen, primarily used in wound repair, dental soft tissue repair, and medical aesthetics. The company is headquartered in Reno, Nevada, and its core product is the CXU biological scaffold material, designed to promote tissue regeneration and healing by mimicking the structure of the extracellular matrix (ECM) in the human body.